financetom
Business
financetom
/
Business
/
European car sales rise 4.9% in October, ACEA says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
European car sales rise 4.9% in October, ACEA says
Nov 24, 2025 9:34 PM

(Reuters) -New car sales in Europe rose 4.9% in October as electric cars outpaced petrol and diesel registrations, European Automobile Manufacturers' Association data showed on Tuesday.

WHY IT'S IMPORTANT

The European car industry has taken a series of hits this year including U.S. President Donald Trump's trade tariffs, a slowdown in the Chinese market, and a slower-than-expected transition to electric vehicles.

Recently, concerns about a potential chip supply chain crisis surrounding Dutch chipmaker Nexperia had also added fuel to the fire.

Meanwhile, Chinese electric car exports to Europe are increasing.

BY THE NUMBERS

Sales in the European Union, Britain and the European Free Trade Association rose to 1.092 million cars in October as its largest markets including Germany and Britain added more new cars than last year, ACEA data showed.

Registrations at Volkswagen, Stellantis ( STLA ) and Renault rose year-on-year by 6.5%, 4.6% and 10.6%, respectively. Despite Stellantis' ( STLA ) registrations being down 4.7% year-to-date compared to the same period in 2024.

Tesla's sales meanwhile dropped 48.5% from a year ago as BYD's sales jumped 206.8%, now holding 1.6% of the market share from 0.5% in October 2024. Registrations of Chinese-owned SAIC Motor also jumped 35.9% from last year.

Total EU car sales rose 5.8%. Registrations of battery electric, plug-in hybrid and hybrid electric cars were up 38.6%, 43.2% and 9.4%, respectively, to account collectively for about 63.9% of the bloc's registrations, up from 55.4% in October 2024.

All major markets saw drops in their petrol and diesel

Overall sales rose 7.8% in Germany, 0.5% in the UK, 15.9% in Spain, 2.9% in France and fell 0.5% in Italy.

QUOTE

"Despite this recent positive momentum, overall volumes remain far below pre-pandemic levels," ACEA said.

"The battery-electric car market share reached 16.4% year to date, yet it is still below the pace needed at this stage of the transition," it added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Okta Insider Sold Shares Worth $267,397, According to a Recent SEC Filing
Okta Insider Sold Shares Worth $267,397, According to a Recent SEC Filing
Feb 13, 2025
05:14 PM EST, 02/13/2025 (MT Newswires) -- Larissa Schwartz, Chief Legal Officer and Corporate Secretary, on February 11, 2025, sold 2,740 shares in Okta ( OKTA ) for $267,397. Following the Form 4 filing with the SEC, Schwartz has control over a total of 22,125 Class A common shares of the company, with 22,125 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1660134/000166013425000030/xslF345X05/wk-form4_1739484346.xml...
Insmed Insider Sold Shares Worth $1,465,680, According to a Recent SEC Filing
Insmed Insider Sold Shares Worth $1,465,680, According to a Recent SEC Filing
Feb 13, 2025
05:11 PM EST, 02/13/2025 (MT Newswires) -- Sara Bonstein, Chief Financial Officer, on February 11, 2025, sold 18,321 shares in Insmed ( INSM ) for $1,465,680. Following the Form 4 filing with the SEC, Bonstein has control over a total of 137,185 common shares of the company, with 137,185 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1104506/000162828025005465/xslF345X05/wk-form4_1739484553.xml ...
BRIEF-Matinas Biopharma Announces Agreement For The Acquisition Of Preferred Stock And Appointment Of Dr. Robin L. Smith To The Board Of Directors
BRIEF-Matinas Biopharma Announces Agreement For The Acquisition Of Preferred Stock And Appointment Of Dr. Robin L. Smith To The Board Of Directors
Feb 13, 2025
Matinas BioPharma Holdings Inc ( MTNB ): * MATINAS BIOPHARMA ANNOUNCES AGREEMENT FOR THE ACQUISITION OF PREFERRED STOCK AND APPOINTMENT OF DR. ROBIN L. SMITH TO THE BOARD OF DIRECTORS Source text: Further company coverage: ...
Leggett & Platt Q4 Adjusted EPS, Sales Decrease
Leggett & Platt Q4 Adjusted EPS, Sales Decrease
Feb 13, 2025
05:13 PM EST, 02/13/2025 (MT Newswires) -- Leggett & Platt ( LEG ) reported Q4 adjusted earnings Thursday of $0.21 per diluted share, down from $0.26 a year earlier. Analysts polled by FactSet expected $0.20. Trade sales for the quarter ended Dec. 31 were $1.06 billion, down from $1.12 billion a year earlier. Analysts surveyed by FactSet expected $1.03 billion....
Copyright 2023-2026 - www.financetom.com All Rights Reserved